Applied Molecular Transport Inc
AMTI
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.01M
Close$
Share Statistics
| Market cap | $11.01 Million |
|---|---|
| Enterprise Value | $-5,743,713.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.23 |
| Beta | 2.29 |
| Outstanding Shares | 39,751,028 |
Return
| Return on Equity | -450.40% |
|---|---|
| Return on Assets | -365.45% |
| Return on Invested Capital | -475.34% |
Valuation & Multiples
| P/E Ratio | -0.08 |
|---|---|
| PEG | 0.11 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.07 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.24 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Applied Molecular Transport Inc
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, m...